Market Overview

Blueprint Medicines (NYSE: BPMC)

102.47 -1.42 (-1.37%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/16/20Raymond JamesMaintainsStrong Buy122.0
10/13/20Morgan StanleyMaintainsOverweight100.0
7/27/20SVB LeerinkMaintainsOutperform107.0
7/15/20Morgan StanleyMaintainsOverweight92.0
7/15/20SVB LeerinkMaintainsOutperform106.0
7/15/20HC Wainwright & Co.MaintainsBuy110.0
6/08/20Deutsche BankMaintainsBuy85.0
5/05/20BarclaysInitiates Coverage OnEqual-Weight59.0
4/30/20Canaccord GenuityMaintainsBuy100.0
4/30/20Morgan StanleyMaintainsOverweight88.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter